Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
1.040
-0.070 (-6.31%)
At close: Nov 4, 2024, 4:00 PM
1.100
+0.060 (5.77%)
After-hours: Nov 4, 2024, 4:28 PM EST
Omega Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -78.9 | -97.43 | -102.7 | -68.28 | -29.45 | -17.95 |
| Depreciation & Amortization | 6.07 | 6.77 | 5.19 | 1.39 | 1.15 | 0.79 |
| Other Amortization | 0.06 | 0.05 | 0.07 | 0.09 | 0.05 | 0.04 |
| Loss (Gain) From Sale of Assets | -0 | -0.23 | - | -0 | 0.03 | - |
| Loss (Gain) From Sale of Investments | 0.01 | -0.19 | 1.05 | 0.03 | - | - |
| Stock-Based Compensation | 9.04 | 8.79 | 7.75 | 3.18 | 0.64 | 0.34 |
| Other Operating Activities | 0.01 | 0.09 | 0.01 | 1.32 | -0.11 | -0.08 |
| Change in Accounts Receivable | 0.51 | -5.51 | -0.36 | -0.26 | - | - |
| Change in Accounts Payable | -4.6 | -1.49 | 0.99 | 1.04 | 0.14 | 0.67 |
| Change in Other Net Operating Assets | 3.19 | -2.37 | -10.51 | 3.88 | 1.43 | 0.51 |
| Operating Cash Flow | -64.6 | -91.51 | -98.52 | -57.61 | -26.13 | -15.68 |
| Capital Expenditures | -2.77 | -2.87 | -1.38 | -1.47 | -1.81 | -0.89 |
| Sale of Property, Plant & Equipment | 0.65 | 0.65 | - | - | - | - |
| Investment in Securities | 7.6 | 49.73 | -16.68 | -38.93 | - | - |
| Investing Cash Flow | 5.49 | 47.52 | -18.06 | -40.4 | -1.81 | -0.89 |
| Long-Term Debt Issued | - | 2.62 | - | 8 | - | 4 |
| Long-Term Debt Repaid | - | -1 | - | - | - | - |
| Net Debt Issued (Repaid) | -0.58 | 1.62 | - | 8 | - | 4 |
| Issuance of Common Stock | 0.03 | 40.49 | 0.71 | 131.51 | 0.1 | 0.02 |
| Other Financing Activities | -0.02 | -0.29 | - | -3.47 | -0.08 | -0.04 |
| Financing Cash Flow | -0.57 | 41.82 | 0.71 | 261.54 | 48.62 | 11.99 |
| Net Cash Flow | -59.69 | -2.17 | -115.87 | 163.53 | 20.68 | -4.58 |
| Free Cash Flow | -67.37 | -94.38 | -99.9 | -59.08 | -27.94 | -16.56 |
| Free Cash Flow Margin | -1066.99% | -3050.39% | -4818.86% | -41025.00% | - | - |
| Free Cash Flow Per Share | -1.22 | -1.75 | -2.09 | -2.64 | -7.15 | -4.99 |
| Cash Interest Paid | 1.69 | 1.72 | 1.26 | 0.75 | 0.73 | 0.56 |
| Levered Free Cash Flow | -41.81 | -60.18 | -57.24 | -34.32 | -16.57 | - |
| Unlevered Free Cash Flow | -40.74 | -59.11 | -56.49 | -33.79 | -16.13 | - |
| Change in Net Working Capital | 2.69 | 9.14 | 3.83 | -4.38 | -1.8 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.